enVVeno Medical Corporati...

2.60
-0.15 (-5.45%)
At close: Mar 31, 2025, 12:35 PM

enVVeno Medical Statistics

Share Statistics

enVVeno Medical has 17.54M shares outstanding. The number of shares has increased by 31.68% in one year.

Shares Outstanding 17.54M
Shares Change (YoY) 31.68%
Shares Change (QoQ) 31.55%
Owned by Institutions (%) 26.53%
Shares Floating 17.37M
Failed to Deliver (FTD) Shares 522
FTD / Avg. Volume 0.51%

Short Selling Information

The latest short interest is 442.4K, so 2.52% of the outstanding shares have been sold short.

Short Interest 442.4K
Short % of Shares Out 2.52%
Short % of Float 2.55%
Short Ratio (days to cover) 2.07

Valuation Ratios

The PE ratio is -2.37 and the forward PE ratio is -2.67. enVVeno Medical's PEG ratio is 0.07.

PE Ratio -2.37
Forward PE -2.67
PS Ratio 0
Forward PS 1
PB Ratio 1.23
P/FCF Ratio -3.07
PEG Ratio 0.07
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for enVVeno Medical Corporation.

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 20.88, with a Debt / Equity ratio of 0.03.

Current Ratio 20.88
Quick Ratio 20.88
Debt / Equity 0.03
Total Debt / Capitalization 2.46
Cash Flow / Debt -15.83
Interest Coverage 0

Financial Efficiency

Return on equity (ROE) is -0.52% and return on capital (ROIC) is -55.12%.

Return on Equity (ROE) -0.52%
Return on Assets (ROA) -0.49%
Return on Capital (ROIC) -55.12%
Revenue Per Employee $0
Profits Per Employee $-589,702.7
Employee Count 37
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax 0
Effective Tax Rate 0

Stock Price Statistics

The stock price has increased by -49.45% in the last 52 weeks. The beta is 1.38, so enVVeno Medical's price volatility has been higher than the market average.

Beta 1.38
52-Week Price Change -49.45%
50-Day Moving Average 3.18
200-Day Moving Average 3.96
Relative Strength Index (RSI) 37.92
Average Volume (20 Days) 102.08K

Income Statement

Revenue n/a
Gross Profit 0
Operating Income -23.83M
Net Income -21.82M
EBITDA -23.83M
EBIT n/a
Earnings Per Share (EPS) -1.27
Full Income Statement

Balance Sheet

The company has 1.75M in cash and 1.06M in debt, giving a net cash position of 690K.

Cash & Cash Equivalents 1.75M
Total Debt 1.06M
Net Cash 690K
Retained Earnings -151.85M
Total Assets 44.95M
Working Capital 41.64M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -16.84M and capital expenditures -37K, giving a free cash flow of -16.88M.

Operating Cash Flow -16.84M
Capital Expenditures -37K
Free Cash Flow -16.88M
FCF Per Share -0.98
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

NVNO does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -46.18%
FCF Yield -35.06%
Dividend Details

Analyst Forecast

Currently there are no analyst rating for NVNO.

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Stock Forecasts

Stock Splits

The last stock split was on Nov 30, 2020. It was a backward split with a ratio of 1:25.

Last Split Date Nov 30, 2020
Split Type backward
Split Ratio 1:25

Scores

Altman Z-Score 5.3
Piotroski F-Score 2